Royal Bank of Canada’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-447
| Closed | – | – | 6570 |
|
2019
Q3 | $0 | Hold |
447
| – | – | ﹤0.01% | 6352 |
|
2019
Q2 | $0 | Sell |
447
-212
| -32% | – | ﹤0.01% | 6181 |
|
2019
Q1 | $1K | Buy |
659
+169
| +34% | +$256 | ﹤0.01% | 5695 |
|
2018
Q4 | $0 | Buy |
490
+51
| +12% | – | ﹤0.01% | 6396 |
|
2018
Q3 | $1K | Sell |
439
-203
| -32% | -$462 | ﹤0.01% | 6038 |
|
2018
Q2 | $2K | Buy |
642
+115
| +22% | +$358 | ﹤0.01% | 5727 |
|
2018
Q1 | $1K | Buy |
527
+265
| +101% | +$503 | ﹤0.01% | 5645 |
|
2017
Q4 | $0 | Sell |
262
-1,234
| -82% | – | ﹤0.01% | 6256 |
|
2017
Q3 | $11K | Buy |
1,496
+1,240
| +484% | +$9.12K | ﹤0.01% | 5492 |
|
2017
Q2 | $2K | Sell |
256
-67
| -21% | -$523 | ﹤0.01% | 5573 |
|
2017
Q1 | $3K | Buy |
323
+87
| +37% | +$808 | ﹤0.01% | 5698 |
|
2016
Q4 | $2K | Buy |
+236
| New | +$2K | ﹤0.01% | 5733 |
|